HLA Testing & Immunopeptidomics Services
Antogen supports pharmaceutical and biotechnology programs with HLA-focused services spanning peptide–HLA complex analysis, clinical HLA typing, and the regulatory and data infrastructure needed to support HLA testing throughout the product lifecycle.
- Peptide–HLA Analysis
- Clinical HLA Typing
- Regulatory & Data
- IMGT/HLA Management
Supported Sample Types
Tissue
Biopsies
Cell Lines
Peripheral Blood
Peptide–HLA Complex Analysis (Discovery & Validation)
Antogen performs peptide–HLA complex analysis to characterize the ligandome presented by cells and tissues — supporting therapeutic target discovery and translational strategy.
Common use cases:
- Mapping peptide–HLA ligands from biologically relevant samples
- Validating the presence and relative abundance of candidate targets
- Supporting patient selection strategies for HLA-restricted therapeutics
- Evaluating potential off-target risks
HLA Typing for Clinical Trial Eligibility
For programs in which HLA status determines patient eligibility or recruitment, Antogen supports the latest HLA typing technologies and regulatory engagement with FDA or other global regulators to support such indications.
Common use cases:
- Determining patient eligibility for clinical trials
- Generating audit-ready reports for clinical development programs
- Supporting consistent testing processes across trial sites
IVD Regulatory Expertise & Data Management
Antogen provides regulatory and data management support to help teams establish the appropriate documentation and evidence package ("dossier") for FDA pathways and international requirements.
Common use cases:
- Regulatory strategy inputs for IVD development
- Data management practices supporting auditability and submission readiness
- Documentation structure and lifecycle planning aligned to diagnostic development
IMGT/HLA Database & Software Lifecycle Management
As HLA allele definitions expand over time, maintaining reference data and software is a lifecycle requirement. Antogen supports IMGT/HLA database and software management to help teams stay current as allele definitions evolve.
Common use cases:
- Clearly defined scope, objectives, endpoints, and timelines
- Secure data collection and organization aligned with client requirements
- Secure data collection and organization aligned with client requirements
- Results reporting tailored to discovery, translational, or clinical programs